Yang Mi Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yang Mi Park has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Hye-Mi Jeon
Dental Clinic Center, Pusan National University Hospital, Busan, Korea
2 shared publications - Kyung-Hee Kim
Department of Oral Medicine Busan Paik Hospital Inje University College of Medicine Busan Korea
2 shared publications - Soo-Min Ok
Dental Research Institute, Pusan National University Dental Hospital, Yangsan, Republic of Korea; Department of Oral Medicine, Dental and Life Science Institute, School of Dentistry, Pusan National University, Yangsan, Republic of Korea
2 shared publications - Sung-Hee Jeong
Department of Oral Medicine, Dental Research Institute, Pusan National University Dental Hospital, Yangsan, Korea
2 shared publications - Yong-Woo Ahn
Department of Oral Medicine, Dental Research Institute, Pusan National University Dental Hospital, Yangsan, Korea
2 shared publications - Eun-Gyo Jeong
Department of Oral Medicine, Dental and Life Science Institute, Pusan National University School of Dentistry, Yangsan, Korea
1 shared publication
Latest Publications
- Open Access
- 1 January 2020
- Published by XMLink in Yonsei Medical Journal
- Vol. 61 (4) , 331-340
Local Injection of Growth Hormone for Temporomandibular Joint Osteoarthritis
Osteoarthritis (OA) of the temporomandibular joint (TMJ) elicits cartilage and subchondral bone defects. Growth hormone (GH) promotes chondrocyte growth. The aim of this study was to evaluate the efficacy of intra-articular injections of GH to treat TMJ-OA. Monosodium iodoacetate (MIA) was used to induce OA in the TMJs of rats. After confirming the induction of OA, recombinant human GH was injected into the articular cavities of rats. Concentrations of GH and IGF-1 were measured in the blood and synovial fluid, and OA grades of cartilage and subchondral bone degradation were recorded by histological examination and micro-computed tomography. MIA-induced OA in the rat TMJ upregulated insulin-like growth factor-1 (IGF-1) rather than GH levels. GH and IGF-1 concentrations were increased after local injection of GH, compared with controls. Locally injected GH lowered osteoarthritic scores in the cartilage and subchondral bone of the TMJ. Intra-articular injection of GH improved OA scores in rat TMJs in both cartilage and subchondral bone of the condyles without affecting condylar bone growth. These results suggest that intra-articular injection of human GH could be a suitable treatment option for TMJ-OA patients in the future.
- 1 January 2020
- Published by XMLink in Yonsei Medical Journal
- Vol. 61 (4) , 331-340
Open AccessLocal Injection of Growth Hormone for Temporomandibular Joint Osteoarthritis
Osteoarthritis (OA) of the temporomandibular joint (TMJ) elicits cartilage and subchondral bone defects. Growth hormone (GH) promotes chondrocyte growth. The aim of this study was to evaluate the efficacy of intra-articular injections of GH to treat TMJ-OA. Monosodium iodoacetate (MIA) was used to induce OA in the TMJs of rats. After confirming the induction of OA, recombinant human GH was injected into the articular cavities of rats. Concentrations of GH and IGF-1 were measured in the blood and synovial fluid, and OA grades of cartilage and subchondral bone degradation were recorded by histological examination and micro-computed tomography. MIA-induced OA in the rat TMJ upregulated insulin-like growth factor-1 (IGF-1) rather than GH levels. GH and IGF-1 concentrations were increased after local injection of GH, compared with controls. Locally injected GH lowered osteoarthritic scores in the cartilage and subchondral bone of the TMJ. Intra-articular injection of GH improved OA scores in rat TMJs in both cartilage and subchondral bone of the condyles without affecting condylar bone growth. These results suggest that intra-articular injection of human GH could be a suitable treatment option for TMJ-OA patients in the future.
- Open Access
- 30 December 2019
- Published by Journal of Oral Medicine and Pain in Journal of Oral Medicine and Pain
- Vol. 44 (4) , 160-168
Interleukin-8 and Matrix Metalloprotease 9 as Salivary Biomarkers of Pain in Patients with Temporomandibular Disorder Myalgia: A Pilot Study
Yang Mi Park, Yong-Woo Ahn, Sung-Hee Jeong, Hye-Min Ju, Hye-Mi Jeon, Kyung-Hee Kim, Soo-Min Ok. JOMP 2019;44:160-8. https://doi.org/10.14476/jomp.2019.44.4.160
- 30 December 2019
- Published by Journal of Oral Medicine and Pain in Journal of Oral Medicine and Pain
- Vol. 44 (4) , 160-168
Open AccessInterleukin-8 and Matrix Metalloprotease 9 as Salivary Biomarkers of Pain in Patients with Temporomandibular Disorder Myalgia: A Pilot Study
Yang Mi Park, Yong-Woo Ahn, Sung-Hee Jeong, Hye-Min Ju, Hye-Mi Jeon, Kyung-Hee Kim, Soo-Min Ok. JOMP 2019;44:160-8. https://doi.org/10.14476/jomp.2019.44.4.160